title: Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology.
authors.forename: N A Mark
authors.initials: NAM
authors.lastname: Estes
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Kovacs
authors.forename: Aaron L
authors.initials: AL
authors.lastname: Baggish
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Myerburg
mesh_terms: D000293:Adolescent; D000328:Adult; D026683:Advisory Committees / Q000592:standards; D000572:American Heart Association; D056352:Athletes; D002309:Cardiology / Q000592:standards*; D018376:Cardiovascular Abnormalities / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D008297:Male; D058573:Performance-Enhancing Substances / Q000008:administration & dosage; D017410:Practice Guidelines as Topic / Q000592:standards; D014481:United States / Q000453:epidemiology; D055815:Young Adult
chemical_list: D058573:Performance-Enhancing Substances
keywords: ACC/AHA Scientific Statements; athletes; cardiovascular abnormalities; drugs; performance-enhancing substances